Truist Financial
MYOV

Truist Financial’s Myovant Sciences Ltd. MYOV Stock Holding History

Truist Financial’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-168,500
Closed -$2.62M – 2899
2021
Q4 		$2.62M Sell
168,500
-45,000
-21% -$859K ﹤0.01% 1150
2021
Q3 		$4.79M Sell
213,500
-82
-0% -$1.8K 0.01% 898
2021
Q2 		$4.86M Buy
213,582
+63,082
+42% +$1.33M 0.01% 894
2021
Q1 		$3.1M Buy
150,500
+24,500
+19% +$558K 0.01% 1032
2020
Q4 		$3.48M Buy
126,000
+87,000
+223% +$1.69M 0.01% 953
2020
Q3 		$548K Buy
39,000
+13,000
+50% +$242K ﹤0.01% 1683
2020
Q2 		$536K Buy
+26,000
New +$354K ﹤0.01% 1584

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Truist Financial's MYOV Position: Q1 2022 in Review

Truist Financial sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 168,500 shares — an estimated $2.62M sold.

Truist Financial first reported a position in MYOV in Q2 2020 and held it in 7 quarters. The position peaked at $4.86M in Q2 2021. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

  • Truist Financial reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 168,500 Myovant Sciences Ltd. shares in Q1 2022, an estimated $2.62M.
  • Truist Financial first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 7 quarters.
  • Truist Financial's Myovant Sciences Ltd. position peaked at $4.86M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.